Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Revenue | 3.37B | 2.80B | 2.36B | 1.43B |
| Cost of revenue | 1.91B | 1.62B | 1.50B | 1.36B |
| Research and development | 428M | 410M | 421M | 465M |
| Selling, general and administrative | 459M | 512M | 550M | 646M |
| Operating income | 65M | −168M | −519M | −1.37B |
| Pre-tax income | 269M | −95M | −466M | −1.73B |
| Income tax | 69M | 63M | 19M | 6M |
| Net income | 200M | −158M | −485M | −1.74B |
| Earnings per share | 0.07 | −0.03 | −0.11 | −0.44 |
| Earnings per share, diluted | 0.06 | −0.03 | −0.11 | −0.44 |
| Metric | 18 Aug 2026 | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|---|---|
| Cash and equivalents | — | 3.43B | 2.96B | 3.14B | 1.95B | 4.99B |
| Receivables | — | 240M | 206M | 196M | — | — |
| Inventory | — | 87M | 59M | 49M | — | — |
| Current assets | — | 8.08B | 6.57B | 5.77B | — | — |
| Total assets | — | 11.98B | 9.30B | 8.79B | — | — |
| Current liabilities | — | 4.63B | 2.59B | 1.48B | — | — |
| Short-term debt | — | 1.68B | 123M | 125M | — | — |
| Long-term debt | — | 373M | 241M | 668M | — | — |
| Total liabilities | — | 5.23B | 2.94B | 2.32B | — | — |
| Equity | — | 6.76B | 6.35B | 6.47B | 6.66B | 8.02B |
| Metric | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Operating cash flow | 79M | 852M | 86M | −798M |
| Share-based compensation | 241M | 279M | 304M | 412M |
| Capital expenditure | 97M | 77M | 71M | 58M |
| Investing cash flow | −782M | −231M | 1.87B | −1.06B |
| Financing cash flow | 1.10B | −771M | −770M | −1.12B |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator